Physician profile
Joel M Biggers
NPI 1215136759
$918.01
in general payments reported to CMS, 2019-2025
12 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $24.45 · 2021: $19.65 · 2022: $77.72 · 2023: $94.99 · 2024: $179 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $569.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $253.84 | 2019-2025 | Trelegy Ellipta |
| Novo Nordisk INC | $244.89 | 2019-2025 | Ozempic, Rybelsus |
| Cashflow Solutions, LLC | $98.63 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Otsuka America Pharmaceutical, INC. | $74.34 | 2024-2025 | Rexulti |
| Pfizer INC. | $57.98 | 2019-2025 | |
| Boston Scientific Corporation | $42.63 | 2023-2025 | Wavewriter Alpha Prime 16, Watchman Flx |
| Abbott Laboratories | $42.25 | 2024-2025 | Freestyle Libre 3 |
| Abbvie INC. | $34.54 | 2025 | |
| Lundbeck LLC | $22.15 | 2024 | Rexulti |
| Novartis Pharmaceuticals Corporation | $15.99 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.75 | 2022 | |
| Xeris Pharmaceuticals, INC. | $15.02 | 2023 | Keveyis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Biggers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.